Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation

Nature Immunology

Volumn 2, Issue 6, 2001, Pages 542-547

  Doody, Gina M ^a,d   Bell, Sarah E ^a   Vigorito, Elena ^a   Clayton, Elizabeth ^a   McAdam, Simon ^a   Tooze, Reuben ^b,e   Fernandez, Claire ^a   Lee, Insong James ^c,f   Turner, Martin ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e LEEDS GENERAL INFIRMARY   (United Kingdom)

^f Epigenesis Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; ONCOPROTEIN; T LYMPHOCYTE ANTIGEN; THYMUS INDEPENDENT ANTIGEN; VAV PROTEIN; VAV1 PROTEIN, MOUSE; VAV2 PROTEIN, MOUSE;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; MOUSE; MOUSE MUTANT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTES; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; MICE; MICE, KNOCKOUT; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; SIGNAL TRANSDUCTION;

EID: 0035378223     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/88748     Document Type: Article

References (39)

1. Acuto, O. & Cantrell, D.A.T cell activation and the cytoskeleton. Annu. Rev. Immunol. 18, 165-184 (2000).
2. Dustin, M. L. & Cooper, J.A. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nature Immunol. 1, 23-29 (2000).
3. Bustelo, X. R. Regulatory and Signalling Properties of the Vav Family. Mol. Cell Biol. 20, 1461-1477 (2000).
4. Henning, S.W. & Cantrell, D.A. GTPases in antigen receptor signalling. Curr. Opin. Immunol. 10, 322-329 (1998).
5. Van Aelst, L. & D'Souza-Schorey, C. Rho GTPases and signalling networks. Genes Dev. 11, 2295-2322 (1997).
6. Bishop, A. B. & Hall, A. Rho GTPases and their effector proteins. Biochem. J. 348, 241-255 (2000).
7. Turner, M. et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7, 451-460 (1997).
8. Kong, Y.Y. et al. Vav regulates peptide-specific apoptosis in thymocytes. J. Exp. Med 188, 2099-2111 (1998).
9. Fischer, K. D. et al. Vav is a regulator of cytoskeletal reorganisation mediated by the T-cell receptor. Curr. Biol. 8, 554-562 (1998).
10. Holsinger, L. J. et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8, 563-572 (1998).
11. Costello, P. S. et al. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-κB pathways. Proc. Natl Acad. Sci. USA 96, 3035-3040 (1999).
12. Tarakhovsky, A. et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374, 467-470 (1995).
13. Zhang, R., Alt, F.W., Davidson, L. Orkin, S.H. & Swat, W. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374, 470-473 (1995).
14. Gulbranson-Judge, A. et al. Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help. Eur. J. Immunol. 29, 477-487 (1999).
15. Bachmann, M. F. et al. The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens. J. Immunol. 163, 137-142 (1999).
16. Billadeau, D. D., Mackie, S. M., Schoon, R.A. & Leibson, P.J. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity. J. Exp. Med. 192, 381-391 (2000).
17. Moores, S. L. et al. Vav family proteins couple to diverse cell surface receptors. Mol. Cell Biol. 20, 6364-6373 (2000).
18. Doody, G. M. et al. Vav-2 controls NFAT-dependent transcription in B-but not T-lymphocytes. EMBO J. 19, 6173-6184 (2000).
19. Soisson, S. M., Nimnual, A. S., Uy, M., Bar-Sagi-D. & Kuriyan, J. Crystal structure of the DbI and pleckstrin homology domains from the human son of sevenless protein. Cell 95, 259-268 (1998).
20. Hardy, R. R., Carmack, C. E., Shinton, S.A., Kemp, J. D. & Hayakama, K. Resolution and characterisation of Pro-Band Pre-Pre-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213-1225 (1991).
21. ™ and exhibit unique signaling characteristics. J. Immunol. 149, 2533-2540 (1992).
22. ™ splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151, 4431-4444 (1993).
23. Loder, F. et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med 190, 75-89 (1999).
24. Bijsterbosch, M. K., Meade, C. J., Turner, G.A. & Klaus, G. G. B. B lymphocyte receptors and polyphosphoinositide degradation. Cell 41, 999-1006 (1985).
25. Healy, J. I. & Goodnow, C. C. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16, 645-670 (1998).
26. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nature Immunol. 1, 31-36 (2000).
27. Sato, S., Steeber, D. A., Jansen, P. J. & Tedder, T. F. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J. Immunol. 158, 4662-4669 (1997).
28. Gardby, E. & Lycke, N.Y. CD19-deficient mice exhibit poor responsiveness to oral immunisation despite evidence of unaltered total IgA levels, germinal centre and IgA-isotype switching in peyer's patches. Eur. J. Immunol. 30, 1861-1871 (2000).
29. Krawczyk, C. et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 13, 463-473 (2000).
30. Meffre, E., Casellas, R. & Nussenzweig, M. C. Antibody regulation of B cell development. Nature Immunol. 1, 379-385 (2000).
31. Lam, K. P., Kuhn, R. & Rajewsky, K. In vivo ablation of surface Ig on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083 (1997).
32. Satterthwaite, A. B., Li, Z. & Witte, O. N. Btk function in B cell development and response. Semin. Immunol. 10, 309-316 (1998).
33. Fruman, D.A., Satterthwaite, A.B. & Witte, O. N. Xid-like Phenotypes: A B cell signalosome takes shape. Immunity 13, 1-3 (2000).
34. Ishiai, M. et al. BLNK required for coupling Syk to PLCg2 and Rac1-JNK in B cells. Immunity 10, 117-125 (1999).
35. Tybulewicz, V. L. J., Crawford, C. E. Jackson, P. K., Bronson, R. T. & Mulligan, R. C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163 (1991).
36. Schuebel, K. E. et al. Isolation and characterization of murine Vav-2, a member of the Vav family of proto-oncogenes. Oncogene 13, 363-371 (1996).
37. Hooper, M., Hardy, K., Handyside, A., Hunter, S. & Monk, M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonisation by cultured cells. Nature 326, 292-298 (1987).
38. Turner, M. et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298-302 (1995).
39. Movilla, N. & Bustelo, X. R. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol. Cell Biol. 19, 7870-7885 (1999).